% | $
Quotes you view appear here for quick access.

Talon Therapeutics, Inc. Message Board

  • perdooky perdooky Nov 14, 2012 1:00 PM Flag

    November 14th Conference Call Highlights

    CC Highlights (last 3 items from bhakes post):

    - Premium pricing strategy applies to Marqibo
    - Commercial launch of Marqibo in US in 2013 Q1
    - Efforts include the development of a comprehensive advertising and promotional campaign, that will debut in leading medical journals this month
    - 3 presentations at the 2012 American Society of Hematology Meeting (December 8-11, 2012) to highlight study data. Also, several booths.
    - As they had all efforts focused on the ODAC meeting this time last year, all efforts are focused on the ASH meeting and commercialization preparation. They expect similarly rewarding results.
    - There was significant effort and travel in the 3rd quarter related to the assessment of several varied strategic transaction opportunities
    - Assessing transactions that will augment Marqibo commercial launch, and help the Marqibo franchise reach its full medical and financial potential
    - It is more probably than not that Marqibo will be launched following a strategic transaction
    - Abundant and serious interest in an asset such as Marqibo stems from that it is already approved, thus de-risked, and ready to take to market. Also, that the Phase 3 trial is already up and running.
    - Menadione is currently in a Phase 2 study. Enrollment has recently accelerated, and no toxicity issues have been encountered. Data available in first half of 2013.
    - Talon currently evaluating different commercialization paths for Marqibo. From Merger & Acquisition (buyout) to licensing agreements (partner) to Talon launching Marqibo alone. The probability is greater for a strategic transaction than Talon launching it on its own
    - Just over 160+MM shares common & converted
    - There are 1700 patients (annually) in the US likely to use Marqibo for ALL
    - The company will submit an application for Marqibo use in Europe in the next year

    SortNewest  |  Oldest  |  Most Replied Expand all replies